StockData
Pharma-Bio Serv, Inc. logo

Pharma-Bio Serv, Inc. (PBSV) stock

PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)

Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –

Pharma-Bio Serv cash

Cash and short-term investments held at the end of each period.

Pharma-Bio Serv's cash was $8.58M at Jul 31, 2026. For fiscal 2025 it was $10.85M, down 14.8% from the year before. Over ten years it grew -3.1% a year on average. The highest annual figure on record is $17.47M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2025Oct 31, 2025$10.85M-14.8%
FY2024Oct 31, 2024$12.75M-14.9%
FY2023Oct 31, 2023$14.98M+3.6%
FY2022Oct 31, 2022$14.46M-17.2%
FY2021Oct 31, 2021$17.47M+1.9%
FY2020Oct 31, 2020$17.14M+10.6%
FY2019Oct 31, 2019$15.49M-3.6%
FY2018Oct 31, 2018$16.07M+38.4%
FY2017Oct 31, 2017$11.62M-15.8%
FY2016Oct 31, 2016$13.79M-7.6%
FY2015Oct 31, 2015$14.93M-1.5%
FY2014Oct 31, 2014$15.16M+25.1%
FY2013Oct 31, 2013$12.12M+82.7%
FY2012Oct 31, 2012$6.63M+50.4%
FY2011Oct 31, 2011$4.41M+82.9%
FY2010Oct 31, 2010$2.41M+17.6%
FY2009Oct 31, 2009$2.05M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jul 31, 2026$8.58M-20.0%
Q2 FY2026CQ1 2026Apr 30, 2026$8.47M-18.6%
Q1 FY2026CQ4 2025Jan 31, 2026$10.56M-15.1%
Q4 FY2025CQ3 2025Oct 31, 2025$10.85M-14.8%
Q3 FY2025CQ2 2025Jul 31, 2025$10.73M-16.6%
Q2 FY2025CQ1 2025Apr 30, 2025$10.41M-22.7%
Q1 FY2025CQ4 2024Jan 31, 2025$12.43M-21.7%
Q4 FY2024CQ3 2024Oct 31, 2024$12.75M-14.9%
Q3 FY2024CQ2 2024Jul 31, 2024$12.86M-11.8%
Q2 FY2024CQ1 2024Apr 30, 2024$13.47M-1.0%
Q1 FY2024CQ4 2023Jan 31, 2024$15.89M+2.7%
Q4 FY2023CQ3 2023Oct 31, 2023$14.98M+3.6%
Q3 FY2023CQ2 2023Jul 31, 2023$14.58M+2.4%
Q2 FY2023CQ1 2023Apr 30, 2023$13.60M+3.3%
Q1 FY2023CQ4 2022Jan 31, 2023$15.47M-11.4%
Q4 FY2022CQ3 2022Oct 31, 2022$14.46M-12.3%
Q1 FY2022CQ4 2021Jul 31, 2022$14.24M-11.4%
Q2 FY2022CQ1 2022Apr 30, 2022$13.16M-30.7%
Q4 FY2021CQ3 2021Oct 31, 2021$17.47M+1.9%
Q3 FY2021CQ2 2021Jul 31, 2021$16.50M-1.9%
Q2 FY2021CQ1 2021Apr 30, 2021$16.07M+3.1%
Q1 FY2021CQ4 2020Jan 31, 2021$18.99M+24.5%
Q4 FY2020CQ3 2020Oct 31, 2020$17.14M+10.6%
Q3 FY2020CQ2 2020Jul 31, 2020$16.81M+13.6%
Q2 FY2020CQ1 2020Apr 30, 2020$15.58M+1.0%
Q1 FY2020CQ4 2019Jan 31, 2020$15.25M-3.4%
Q4 FY2019CQ3 2019Oct 31, 2019$15.49M-3.6%
Q3 FY2019CQ2 2019Jul 31, 2019$14.80M-2.4%
Q2 FY2019CQ1 2019Apr 30, 2019$15.43M+19.1%
Q1 FY2019CQ4 2018Jan 31, 2019$15.80M+20.6%
Q4 FY2018CQ3 2018Oct 31, 2018$16.07M+38.4%
Q3 FY2018CQ2 2018Jul 31, 2018$15.16M+23.9%
Q2 FY2018CQ1 2018Apr 30, 2018$12.95M+1.8%
Q1 FY2018CQ4 2017Jan 31, 2018$13.10M-4.3%
Q4 FY2017CQ3 2017Oct 31, 2017$11.62M-15.8%
Q3 FY2017CQ2 2017Jul 31, 2017$12.23M-12.9%
Q2 FY2017CQ1 2017Apr 30, 2017$12.73M–
Q1 FY2017CQ4 2016Jan 31, 2017$13.69M–
Q4 FY2016CQ3 2016Oct 31, 2016$13.79M–
Q3 FY2016CQ2 2016Jul 31, 2016$14.04M–

More Pharma-Bio Serv figures

See a number that looks wrong?